WEGARAB-DSR

WEGARAB-DSR Capsules is an effective gastroprotective and prokinetic combination from Orfit Pharmaceutical Pvt. Ltd., formulated to provide long-lasting relief from acid-related gastrointestinal disorders. It contains Rabeprazole Sodium 20 mg, a proton pump inhibitor that suppresses excess gastric acid secretion, along with Domperidone 30 mg, a prokinetic agent that improves gastric motility and helps prevent nausea and reflux. This combination is commonly prescribed for the treatment of gastroesophageal reflux disease (GERD), acid reflux, heartburn, peptic ulcers, gastritis, and dyspepsia associated with delayed gastric emptying. Rabeprazole helps heal acid-related damage to the stomach and esophagus, while domperidone enhances gastric movement, reducing bloating, nausea, and regurgitation, and improving overall digestive comfort. WEGARAB-DSR Capsules offer both acid control and symptom relief, helping restore normal digestive function when used as directed by a healthcare professional. Manufactured under stringent quality and safety standards, WEGARAB-DSR reflects Orfit Pharmaceutical Pvt. Ltd.’s commitment to delivering reliable, effective, and patient-friendly solutions for comprehensive gastrointestinal care.